PlainPharmaWatch

CMS Open Payments · Program Year 2024

Smisson-Cartledge Biomedical

Smisson-Cartledge Biomedical reported $1,301,590.90 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 16 transactions.

See the rankings → How this is sourced
$1.3M
All-tracks total
16
Transactions
0
Recipients
#559
of 1,925 companies

Smisson-Cartledge Biomedical reported $1,301,590.90 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #559 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer smisson-cartledge-biomedical Smisson-Cartledge Biomedical

$1.3M · #559/1,925 · 0.0% industry · PY2024

  • TOT $1.3M
  • RANK #559
  • SHARE 0.0%
  • TXN 16
  • RCP 0
  • CAT 0
  • GEN n/a
  • PY 2024

Volume peers

Nearest volume peer: Sonendo Inc ($1.3M)

Erbe Elektromedizin GmbH$1.3MEndolumik, Inc.$1.3MSmisson-Cartledge Biomedical…$1.3MSonendo Inc$1.3MMylan Technologies Inc.$1.3M
All-tracks payment totals near Smisson-Cartledge Biomedical (CMS Open Payments PY2024)

Smisson-Cartledge Biomedical sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Smisson-Cartledge Biomedical

In Program Year 2024, Smisson-Cartledge Biomedical reported $1,301,590.90 in payments to 0 physicians and teaching hospitals across 16 individual transactions, an average of $81.3K per transaction and $0.00 per recipient. That total places Smisson-Cartledge Biomedical at rank #559 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Smisson-Cartledge Biomedical.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Smisson-Cartledge Biomedical's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.